High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
about
The promise of neuroprotective agents in Parkinson's diseaseCalcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expressionCommon variants of the vitamin D binding protein gene and adverse health outcomesDietary vitamin D3 supplements reduce demyelination in the cuprizone modelDietary factors in the etiology of Parkinson's disease.Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifyingRisk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice.Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.Novel therapeutic strategies in Parkinson's disease.Vitamin D receptor gene as a candidate gene for Parkinson disease.Serum vitamin D and the risk of Parkinson disease.The effects of uric Acid, serum vitamin d3, and their interaction on Parkinson's disease severityAmelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's diseaseIncidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.Osteoporosis and Parkinson's disease.Vitamin D receptor gene polymorphisms and Parkinson's disease in a population with high ultraviolet radiation exposure.Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson's Disease: A Meta-Analysis Assessment.Role of vitamin d in Parkinson's disease.Mortality and Revision Surgery Are Increased in Patients With Parkinson's Disease and Fractures of the Femoral Neck.Vitamin D: more than just affecting calcium and bone.Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia.Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson's disease.Outdoor work and risk for Parkinson's disease: a population-based case-control study.Parkinson's disease and resistive exercise: rationale, review, and recommendations.Association between serum biochemical levels, related to bone metabolism and Parkinson's diseaseBone mass and vitamin D levels in Parkinson's disease: is there any difference between genders?The relationship between balance control and vitamin D in Parkinson's disease-a pilot studySerum 25-hydroxyvitamin D3 concentration in Iranian patients with Parkinson's diseaseAnti-fracture efficacy of risedronic acid in men: A meta-analysis of randomized controlled trials.Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study.Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fracturesPotential influences of complementary therapy on motor and non-motor complications in Parkinson's disease.The emerging role of nutrition in Parkinson's disease.Memory, mood, and vitamin D in persons with Parkinson's disease.Vitamin D and Parkinson's disease.Musculoskeletal problems in Parkinson's disease.Parkinson disease and exercise.Vitamin D as a potential therapy in amyotrophic lateral sclerosis.
P2860
Q21129436-6549B32A-8626-48FF-87FF-CC02662394C9Q24339450-88884669-D255-42E0-8D4D-653A44359FBDQ24596671-224E37FB-1022-4EA5-882C-EB4F0F016844Q27316475-240BBEBB-C1D5-428B-82F6-C3A6AD6B5A30Q28085390-2E2024B7-D3B2-43A0-9EFE-AD3856E67C0AQ28732683-99AF920A-C570-468A-B79E-E76A36AB5C95Q30248491-1E933A00-A2A7-4753-954A-C9ABB5B367A9Q30300817-B6F7A65E-725B-449D-B926-B43B16D7CFA3Q34328940-5ACC5BF0-548B-4210-92D3-6529A4471E60Q34598371-F46E56CA-7EFD-4D3C-A0E2-DC20929C21CFQ34612832-904184B6-7807-432D-9EBE-75C2BEE570ACQ34796120-37B96534-1823-4ED4-AA9F-3C32BD910420Q34962536-77CFC83C-2A19-43AF-98B8-E102E1C34C33Q35162492-65C0F0F2-FAC8-47EF-B5B4-6AD586D25A34Q35449122-C6272175-556A-4968-91C3-9042E7112866Q35467810-0A46AD3A-4DCE-44E3-B272-1E64BA5C2208Q35755681-2C50A602-5E1D-4647-B44E-48CCB3BDFB8EQ35772154-CECB24ED-D3B4-4281-ADB0-AAECAA13A264Q35809016-221EFC55-59C9-4654-9B05-C27BB16177EEQ35949729-4F7B23AE-85AF-436B-A2FF-EA947CC9A455Q36037846-E664B597-22E4-452D-BE6D-76069D7CAD76Q36262457-2EAA2533-89F5-4B6F-A457-E0510A6CA109Q36480203-59AC0BE7-ECE9-4A12-8546-5FFADEC6CA17Q36803644-8B49CA6C-9377-4F7C-A5EF-2B3825684344Q36885528-DFBF27F1-B14E-4092-A973-C774A4DA233CQ36951205-07EB32EC-6501-40ED-9391-AE3B54D886CFQ37095001-2037570D-93E6-4F84-A243-FA651C4FB162Q37232448-6D5739D1-3B3F-4948-B965-981459A56A59Q37265356-B5BE8310-D472-4730-ADFB-77657360C1FAQ37311744-28D02E97-2831-4AC9-B09B-888344591770Q37444100-825890C8-BCB7-41ED-946F-D8996F7B4C1DQ37463473-12D3FF73-E52D-4D2C-A059-1F1CB1883B25Q37571853-8982E65C-B84D-4E63-A50A-3D1135F93129Q37594078-26079DF6-3061-4324-BB3E-32343E844906Q37622710-15E5B852-DCA9-4214-B05E-0E0BC0A7FD23Q37663957-2323E774-C1B9-40BC-B170-2F94D266EBE8Q38038831-5E8FE961-AA0D-4BF2-9CC1-581A86EA6D1FQ38082685-F8B0292C-7F1A-44BC-934D-40AA945A2313Q38110523-959101DB-4435-4992-BE36-782408340162Q38178758-9F435852-FAE3-486C-A161-A52447A60460
P2860
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
@en
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
@nl
type
label
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
@en
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
@nl
prefLabel
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
@en
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
@nl
P2093
P921
P356
P1433
P1476
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
@en
P2093
P304
P356
10.1212/WNL.49.5.1273
P407
P577
1997-11-01T00:00:00Z